This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
518 |
4. Check minimum number of eventsNone |
518 |
5. Include endpointsNone |
518 |
6. Filter based on genotype QC (FinnGen only) |
484 |
Control definitions (FinnGen only)
- Control exclude
- F5_BEHEMOCHILD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F90-F98
- Name in latin
- Perturbationes ticiformes
Similar endpoints
↥List of similar endpoints to
Tic disorders
based on the number of shared cases.
Similar with more cases:
- Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 484 | 253 | 231 |
| Unadjusted period prevalence (%) | 0.10 | 0.09 | 0.11 |
| Median age at first event (years) | 15.17 | 17.85 | 12.22 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 518
- Matched controls
- 5180
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F95.9
ICD-10 Finland
Tic disorder, unspecified
3249.0
215.2
193
*
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
+∞
207.7
185
*
N05AX08
ATC
risperidone; systemic
13.6
140.3
152
154
F90.0
ICD-10 Finland
Disturbance of activity and attention
14.8
119.3
117
100
F95.0
ICD-10 Finland
Transient tic disorder
668.1
112.4
107
*
N05AX12
ATC
aripiprazole; systemic
11.5
97.7
113
123
N06BA04
ATC
methylphenidate; oral
12.3
97.1
106
106
F95.1
ICD-10 Finland
Chronic motor or vocal tic disorder
+∞
97.0
90
*
N05AD01
ATC
haloperidol; systemic
25.0
85.7
62
28
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.9
76.5
182
435
N03AE01
ATC
clonazepam; systemic
12.1
66.9
71
67
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
28.2
64.1
44
17
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
7.4
52.4
83
130
F84.5
ICD-10 Finland
Asperger syndrome
22.7
51.1
38
18
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
9.1
50.2
65
80
ZY010
NOMESCO Finland
Hospital outpatient
5.8
48.2
100
205
IGY99
NOMESCO Finland
Other psychiatric treatment contact
8.0
46.0
67
95
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
6.6
45.2
80
140
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
8.0
44.2
64
90
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
15.0
42.9
39
28
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
8.4
41.6
57
75
N06AB06
ATC
sertraline; oral
4.4
41.5
124
343
N05AH04
ATC
quetiapine; oral
3.8
41.1
166
570
N06AB03
ATC
fluoxetine; oral
5.0
39.9
98
231
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
5.8
39.6
79
155
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
5.7
39.0
80
161
N05AH03
ATC
olanzapine; systemic
5.5
37.6
81
170
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
8.9
34.7
45
55
ZYC01
NOMESCO Finland
Remote contact by phone
5.6
34.2
71
144
IGP01
NOMESCO Finland
Psychiatric family contact
8.5
32.8
44
56
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
7.1
31.7
50
77
F95.8
ICD-10 Finland
Other tic disorders
+∞
31.6
30
*
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
74.8
31.3
35
5
N05BA04
ATC
oxazepam; oral
3.2
31.0
159
622
30620
ICD-8 Finland
Special symptoms not elsewhere classified, Tics
+∞
30.5
29
*
N03AX09
ATC
lamotrigine; oral
5.4
29.4
62
127
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.9
28.8
69
158
IGY02
NOMESCO Finland
Psychiatric monitoring contact
5.0
27.9
64
141
Z2445
NOMESCO Finland
Psychologist
4.2
27.5
81
218
F93.89
ICD-10 Finland
Other childhood emotional disorders
56.7
27.5
32
6
IGV01
NOMESCO Finland
Psychiatric network contact
8.7
26.8
35
43
N06AX16
ATC
venlafaxine; oral
3.6
26.5
103
336
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.2
25.3
74
198
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.2
25.1
120
445
N05BA01
ATC
diazepam; systemic, rectal
3.9
24.6
79
226
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.9
24.5
57
127
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.0
24.1
135
547
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
7.6
24.0
35
49
N06AX12
ATC
bupropion; oral
3.9
23.5
75
213
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.5
23.5
62
153
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
5.3
22.7
48
98
N03AG01
ATC
valproic acid; systemic, rectal
4.6
22.7
57
135
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
8.9
22.1
28
33
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.5
21.8
84
271
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
7.1
21.5
33
49
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
5.5
19.7
39
75
T36
ICD-10 Finland
Poisoning by systemic antibiotics
5.0
19.3
43
92
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.2
19.2
87
309
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.2
19.0
53
136
N06BA12
ATC
lisdexamfetamine; oral
19.7
18.8
28
15
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
5.8
18.6
35
64
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
14.3
18.5
31
23
Z3231
NOMESCO Finland
Registered nurse
2.4
18.5
183
967
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.8
18.3
43
96
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.0
18.2
55
150
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
7.2
18.0
27
39
N06AX26
ATC
vortioxetine; oral
3.3
17.6
72
240
N06BA09
ATC
atomoxetine; oral
32.7
17.2
22
7
N06AB10
ATC
escitalopram; oral
2.4
17.0
146
719
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
5.4
17.0
34
66
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
+∞
16.8
16
*
N06AB05
ATC
paroxetine; oral
5.0
16.6
37
79
Z2446
NOMESCO Finland
Social worker
3.0
15.9
79
295
N06AB04
ATC
citalopram; systemic
2.9
15.8
83
320
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
+∞
15.7
15
*
N06AX11
ATC
mirtazapine; oral
2.3
15.7
156
817
C07AA05
ATC
propranolol; systemic
2.4
15.6
127
608
SPAT1240
SPAT
Therapeutic discussion
2.6
15.6
104
453
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.5
15.4
56
173
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
46.5
15.2
18
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.0
15.1
73
268
SPAT1243
SPAT
Psychiatric/psychological examination
3.9
14.9
46
127
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.5
14.8
53
162
N05AG02
ATC
pimozide; oral
+∞
14.6
14
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.3
13.5
23
38
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.9
13.5
30
64
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.2
13.4
56
189
F83
ICD-10 Finland
Mixed specific developmental disorders
5.0
13.2
29
61
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
11.4
13.1
24
22
IEV99
NOMESCO Finland
Other psychiatric network intervention
10.4
13.1
25
25
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
5.2
13.0
27
54
SPAT1307
SPAT
Psychosocial counselling and guidance
2.5
12.8
88
388
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
12.7
12.7
22
18
G24.5
ICD-10 Finland
Blepharospasm
71.7
12.6
14
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.5
12.6
46
142
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
+∞
12.5
12
*
P99
ICPC
Psychological disorders other
4.6
12.5
30
68
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
9.3
12.4
25
28
N03AX12
ATC
[U] gabapentin; oral
2.9
12.2
63
239
N03AF01
ATC
carbamazepine; oral, rectal
5.4
12.1
24
46
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.4
11.9
45
142
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.5
11.8
42
128
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
11.7
123
649
N06AA04
ATC
clomipramine; systemic
11.5
11.6
21
19
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.3
11.4
100
490
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
9.2
11.4
23
26
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.2
11.4
31
78
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.8
11.3
35
97
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
4.8
11.1
25
54
N06AX21
ATC
duloxetine; oral
2.8
10.9
56
212
R42
ICD-10 Finland
Dizziness and giddiness
2.4
10.9
86
402
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.6
10.9
37
109
P29
ICPC
Psychological sympt/compl other
2.5
10.9
77
343
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.0
10.8
51
184
G51.3
ICD-10 Finland
Clonic hemifacial spasm
61.3
10.7
12
*
P74
ICPC
Anxiety disorder/anxiety state
2.9
10.6
52
192
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
9.5
10.6
21
23
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
5.0
10.6
23
48
XA800
NOMESCO Finland
Neuropsychological investigation
3.2
10.5
44
148
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.4
10.5
39
122
F95
ICD-10 Finland
Tic disorders
112.2
10.5
11
*
N04AA02
ATC
biperiden; systemic
12.4
10.4
18
15
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
16.5
10.4
16
10
F80.1
ICD-10 Finland
Expressive language disorder
4.6
10.4
25
57
IAZ98
NOMESCO Finland
Other internal psychiatric consultation
23.9
10.3
14
6
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.1
10.2
28
71
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
10.1
62
258
N05CF01
ATC
zopiclone; oral
2.2
9.9
97
496
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.4
9.8
36
112
N03AX16
ATC
[U] pregabalin
2.4
9.8
75
346
F99
ICD-10 Finland
Mental disorder, not otherwise specified
4.4
9.7
24
56
F88
ICD-10 Finland
Other disorders of psychological development
15.4
9.6
15
10
F84.8
ICD-10 Finland
Other pervasive developmental disorders
17.9
9.4
14
8
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
30.6
9.4
12
*
P27
ICPC
Fear of mental disorder
4.5
9.4
23
53
N05BE01
ATC
buspirone; oral
5.0
9.4
20
41
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
9.2
107
582
T82
ICPC
Obesity
3.7
9.2
29
81
Z00.8
ICD-10 Finland
Other general examinations
2.5
9.2
61
263
F50.9
ICD-10 Finland
Eating disorder, unspecified
4.9
9.1
20
42
R53
ICD-10 Finland
Malaise and fatigue
2.0
8.9
124
719
F34.1
ICD-10 Finland
Dysthymia
3.7
8.8
28
79
SPAT1389
SPAT
Visit based on need for special support
2.5
8.8
57
243
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.1
8.8
36
120
F45.8
ICD-10 Finland
Other somatoform disorders
2.6
8.7
53
219
N05AB03
ATC
perphenazine; systemic, rectal
4.5
8.7
21
48
N05CD07
ATC
temazepam; oral
3.6
8.6
29
85
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.2
8.6
23
57
L01
ICPC
Neck symptom/complaint
2.1
8.6
86
442
F84.0
ICD-10 Finland
Childhood autism
28.0
8.5
11
*
F31.8
ICD-10 Finland
Other bipolar affective disorders
4.4
8.5
21
49
C02AC02
ATC
guanfacine; oral
91.5
8.4
9
*
F39
ICD-10 Finland
Unspecified mood [affective] disorder
4.1
8.4
23
58
ZY000
NOMESCO Finland
Hospital inpatient
4.8
8.4
19
41
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.1
8.4
36
123
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
8.7
8.4
17
20
F91.9
ICD-10 Finland
Conduct disorder, unspecified
+∞
8.4
8
*
F98.02
ICD-10 Finland
Non-organic nocturnal and diurnal enuresis
+∞
8.4
8
*
N05AA02
ATC
levomepromazine; systemic
4.2
8.3
22
54
N02BF02
ATC
pregabalin; oral
3.5
8.3
29
87
N06AA09
ATC
amitriptyline; systemic
3.5
8.3
29
87
F61.0
ICD-10 Finland
Mixed personality disorders
9.7
8.3
16
17
P76
ICPC
Depressive disorder
2.5
8.3
54
231
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.2
8.2
32
103
N05BA12
ATC
alprazolam; oral
2.9
8.2
39
142
P10
ICPC
Stammering/stuttering/tic
33.9
8.1
10
*
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.3
7.9
30
95
M03BX01
ATC
baclofen; systemic
7.9
7.9
17
22
H53.1
ICD-10 Finland
Subjective visual disturbances
3.1
7.9
33
111
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
3.4
7.9
29
90
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.9
7.8
121
726
R4110
NOMESCO Finland
Physiotherapy
1.9
7.7
124
752
R25.3
ICD-10 Finland
Fasciculation
18.7
7.6
11
6
P03
ICPC
Feeling depressed
2.0
7.5
96
538
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
7.5
196
1364
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
7.5
59
274
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
7.5
104
601
D01
ICPC
Abdominal pain/cramps general
2.0
7.5
96
540
F89
ICD-10 Finland
Unspecified disorder of psychological development
13.6
7.4
12
9
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
13.6
7.4
12
9
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.4
7.3
54
244
N06AX22
ATC
agomelatine; oral
4.2
7.3
19
46
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
9.6
7.3
14
15
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
+∞
7.3
7
*
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
+∞
7.3
7
*
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
+∞
7.3
7
*
IEP99
NOMESCO Finland
Other psychiatric family intervention
5.9
7.3
19
33
SPAT1058
SPAT
PEF monitoring instruction
2.7
7.2
39
152
S18
ICPC
Laceration/cut
1.7
7.1
185
1285
M79.6
ICD-10 Finland
Pain in limb
1.7
7.1
174
1189
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
7.0
102
597
IEP03
NOMESCO Finland
Focused parental counselling
6.0
7.0
18
31
N05BA06
ATC
lorazepam; systemic, sublingual
3.7
6.9
22
62
N05AF01
ATC
flupentixol; systemic
14.0
6.9
11
8
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
6.9
144
939
Z08
ICPC
Social welfare problem
8.4
6.9
14
17
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.5
6.8
41
169
G24.9
ICD-10 Finland
Dystonia, unspecified
40.6
6.8
8
*
R4170
NOMESCO Finland
Therapy forms involving educational rehabilitation
40.6
6.8
8
*
IAZ99
NOMESCO Finland
Other psychiatric consultation
17.0
6.8
10
6
RT420, ,
NOMESCO Finland
17.0
6.8
10
6
R25.8
ICD-10 Finland
Other and unspecified abnormal involuntary movements
17.0
6.8
10
6
D09
ICPC
Nausea
2.2
6.8
58
280
A02BC02
ATC
pantoprazole; systemic
1.6
6.7
219
1605
ICA03
NOMESCO Finland
Psychiatric treatment plan, outsourced psychotherapy
22.9
6.7
9
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
6.7
77
416
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.8
6.6
33
123
SPAT1241
SPAT
Extensive assessment of psychosocial situation
4.3
6.6
17
41
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
6.6
95
554
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
10.2
6.6
12
12
L28
ICPC
Limited function/disability (L)
2.2
6.5
53
250
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
4.0
6.5
18
46
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.3
6.5
52
244
Z3226
NOMESCO Finland
Physiotherapist
1.9
6.4
94
550
F98.01
ICD-10 Finland
Non-organic diurnal enuresis
70.7
6.4
7
*
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
6.4
88
505
SPAT1395
SPAT
Health check-up of persons outside student and working life
5.6
6.3
17
31
Z01
ICPC
Poverty/financial problem
18.3
6.3
9
5
F91.3
ICD-10 Finland
Oppositional defiant disorder
+∞
6.3
6
*
Z2221
NOMESCO Finland
Medical doctor
1.7
6.2
125
804
N07BB01
ATC
disulfiram; oral
3.6
6.2
20
57
P01
ICPC
Feeling anxious/nervous/tense
1.7
6.2
130
846
A28
ICPC
Limited function/disability NOS
2.4
6.2
44
196
Z71.8
ICD-10 Finland
Other specified counselling
1.6
6.1
176
1244
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
3.3
6.1
23
73
XKD00
NOMESCO Finland
Uroflowmetry
2.6
6.1
36
147
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
5.7
6.0
16
29
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.2
6.0
51
245
AA1AD
NOMESCO Finland
CT of head and brain
1.9
6.0
76
424
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
181
912
2.51
20.66
2.7
3.2
2.38
2.37
mmol/l
0.39
159
823
133
591
2.68
19.55
2.5
1.6
1.52
1.37
%
1.85
121
548
400
2922
2.62
19.09
4.2
3.5
14.46
14.54
pmol/l
0.27
366
2635
231
1417
2.14
15.62
2.6
2.7
68.25
70.49
nmol/l
0.61
222
1320
175
967
2.22
15.39
1.9
1.6
100.59
99.63
pmol/l
0.11
98
489
433
3440
2.58
14.70
5.1
4.1
1.88
1.85
mu/l
0.28
412
3209
397
3063
2.27
13.98
3.8
2.9
5.63
5.59
mmol/l
0.24
375
2813
335
2424
2.08
13.92
7.1
6.3
87.94
85.06
u/l
0.39
318
2280
111
535
2.37
13.28
1.6
1.3
18.48
20.20
nmol/l
0.73
100
467
447
3660
2.61
13.24
14.1
10.9
139.54
139.54
mmol/l
0.00
441
3529
191
1151
2.04
12.99
3.4
3.3
27.81
32.26
u/l
1.95
182
1097
447
3670
2.59
12.98
14.2
10.9
3.92
3.92
mmol/l
0.02
439
3527
97
446
2.45
12.86
1.5
1.6
423.08
16919637.48
pmol/l
0.50
83
396
233
1521
1.97
12.52
7.8
7.9
1.22
1.22
mmol/l
0.01
204
1330
136
737
2.15
12.16
2.9
2.2
167.61
360.91
u/l
1.17
128
697
158
912
2.05
11.92
3.6
3.9
9.05
8.71
mmol/l
0.26
139
830
345
2604
1.97
11.74
4.4
3.7
8.83
8.18
mm/h
0.41
318
2412
225
1482
1.92
11.51
6.0
6.0
11.38
11.83
umol/l
0.14
214
1385
79
347
2.51
11.49
1.6
1.7
1128.79
1145.98
nmol/l
0.06
64
268
185
1190
1.86
9.83
4.9
6.1
37.96
37.69
g/l
0.26
174
1123
93
475
2.17
9.49
6.0
7.0
0.85
0.82
mmol/l
1.07
86
452
133
786
1.93
9.07
2.7
3.2
1.01
1.02
kg/l
0.38
11
108
287
2141
1.76
9.05
6.9
7.5
31.93
31.97
%
0.02
274
2056
208
1415
1.79
9.03
6.9
7.8
1.22
1.22
mmol/l
0.00
194
1320
149
921
1.87
8.82
2.8
2.5
52.22
58.18
u/l
0.71
139
856
310
2375
1.76
8.81
10.3
9.8
3.72
3.85
e9/l
0.56
270
2064
329
2581
1.75
8.43
4.1
3.0
30.65
32.70
u/l
0.45
313
2475
279
2103
1.71
8.15
6.9
7.4
52.76
53.70
%
0.67
267
2018
461
4087
2.16
7.18
10.5
8.1
27.69
27.34
u/l
0.14
451
3945
170
1155
1.70
7.06
3.3
3.6
—
—
—
0
0
133
848
1.76
6.91
3.6
2.8
31.94
39.45
ng/l
0.17
67
401
23
69
3.44
6.63
1.6
1.5
—
—
—
0
0
248
1878
1.61
6.62
3.1
2.9
76.76
72.96
ug/l
0.18
232
1763
292
2315
1.60
6.33
4.3
3.8
6074.80
541.90
e6/l
—
5
30
132
863
1.71
6.20
2.9
2.7
2.70
2.69
mg/l
0.03
114
732
252
1971
1.54
5.52
4.4
5.0
6.20
6.38
mmol/l
0.72
228
1784
376
3237
1.59
5.17
3.5
3.2
4.47
4.57
mmol/l
1.08
362
3074
376
3242
1.58
5.09
3.7
3.3
2.73
2.77
mmol/l
0.43
358
3051
372
3208
1.57
4.95
3.4
3.1
1.38
1.41
mmol/l
0.77
353
3040
324
2712
1.52
4.94
4.2
4.0
36.88
37.52
mmol/mol
0.56
308
2574
365
3137
1.55
4.90
12.8
8.5
100.71
100.44
ml/min/173m2
0.07
297
2369
152
1085
1.57
4.89
5.3
7.7
1.09
1.12
inr
0.27
55
352
40
194
2.15
4.64
1.8
1.7
—
—
—
0
0
222
1745
1.48
4.45
4.7
4.5
0.00
0.00
estimate
-0.00
47
361
69
415
1.76
4.29
2.9
2.8
2.42
2.42
mmol/l
0.04
63
359
15
39
3.93
4.22
1.0
1.1
—
—
—
0
0
177
1346
1.48
4.13
1.5
1.6
0.60
1.59
u/ml
2.16
40
309
135
971
1.53
4.12
3.3
3.3
0.27
0.25
e6/l
0.11
104
730
222
1765
1.45
4.11
3.5
3.2
0.00
0.00
estimate
-0.00
45
345
56
321
1.83
4.08
1.3
1.3
240.57
356.67
u/ml
0.60
51
295
446
4076
1.68
4.05
14.1
10.3
18.80
21.96
mg/l
1.61
336
2926
11
22
5.08
4.02
1.3
2.5
11.03
17.94
umol/l
1.34
11
22
48
265
1.89
3.93
5.1
5.8
—
—
—
0
0
352
3066
1.46
3.90
3.2
2.9
1.22
1.21
mmol/l
0.06
335
2897
56
327
1.80
3.85
2.1
2.5
185.56
32.34
u/l
0.47
48
274
498
4726
2.39
3.79
20.7
14.9
40.72
41.77
%
0.52
475
4526
498
4732
2.36
3.67
20.6
14.7
4.66
4.65
e12/l
0.07
480
4574
217
1750
1.41
3.59
3.4
3.2
0.00
0.00
estimate
-0.00
45
359
497
4723
2.29
3.58
20.7
14.8
260.28
258.46
e9/l
0.27
482
4570
64
397
1.70
3.58
4.2
4.4
8.67
6.99
umol/l
0.17
55
329
498
4737
2.33
3.57
20.7
14.8
137.15
137.57
g/l
0.27
492
4680
9
17
5.37
3.52
3.2
7.4
16.66
19.65
ug/l
—
9
17
124
906
1.48
3.46
3.2
3.4
0.00
0.00
estimate
0.50
45
350
16
59
2.77
3.35
1.2
1.5
—
—
—
0
0
66
421
1.65
3.33
1.1
1.0
—
—
—
0
0
36
192
1.94
3.29
1.6
1.7
—
—
—
0
0
78
522
1.58
3.25
1.4
1.2
17.99
26.07
iu/ml
0.44
18
162
8
15
5.40
3.20
1.0
1.2
—
—
—
0
0
8
15
5.40
3.20
1.0
1.2
—
—
—
0
0
81
551
1.56
3.14
3.4
3.0
2.12
2.81
e6/l
0.54
52
293
102
734
1.49
3.05
2.4
2.8
10.61
6.01
e6/l
1.39
87
657
13
46
2.87
2.94
1.0
1.1
—
—
—
0
0
11
32
3.49
2.91
3.9
2.4
40036.36
41128.28
ug/l
0.08
11
32
82
573
1.51
2.82
3.3
2.9
0.59
0.72
e6/l
0.37
53
311
75
515
1.53
2.80
7.2
8.5
1.14
1.19
mmol/l
0.87
70
488
45
272
1.72
2.79
2.1
1.8
—
—
—
0
0
7
14
5.05
2.73
1.0
1.1
—
—
—
0
0
7
14
5.05
2.73
1.0
1.1
—
—
—
0
0
7
14
5.05
2.73
1.0
1.3
—
—
—
0
0
12
41
2.97
2.63
1.1
1.2
—
—
—
0
0
39
231
1.74
2.61
1.1
1.3
2.98
3.00
u/ml
0.00
27
160
105
783
1.43
2.60
1.7
1.6
1.53
1.36
mmol/l
0.77
90
697
47
294
1.66
2.58
5.6
7.6
1.49
1.44
mmol/l
0.09
47
285
45
279
1.67
2.56
3.2
3.0
31.94
31.01
%
0.18
32
205
70
484
1.52
2.54
3.1
3.8
483.05
1278.52
ng/l
1.47
57
380
67
461
1.52
2.48
1.8
1.8
—
—
—
0
0
410
3786
1.40
2.47
17.5
13.0
13.70
13.76
%
0.12
405
3721
163
1321
1.34
2.42
3.3
3.1
—
—
—
0
0
98
732
1.42
2.40
3.0
2.8
1.08
1.07
mg/l
0.01
61
508
5
8
6.30
2.37
1.2
1.0
8.60
18.38
u/l
—
5
8
16
71
2.29
2.36
1.3
1.2
—
—
—
0
0
9
28
3.25
2.31
1.1
1.0
256.11
301.52
mg/l
—
9
23
12
47
2.59
2.28
1.1
1.1
—
—
—
0
0
52
345
1.56
2.28
1.2
1.2
134.89
131.71
iu/ml
0.02
17
116
33
195
1.74
2.25
3.8
4.6
1.22
1.23
mmol/l
0.76
26
174
67
472
1.48
2.23
4.2
7.5
1.96
1.44
mmol/l
1.02
54
376
35
212
1.70
2.19
1.1
1.2
4.09
6.99
u/ml
0.94
25
155
47
309
1.57
2.15
1.8
1.7
—
—
—
0
0
26
147
1.81
2.06
1.6
1.5
—
—
—
0
0
54
372
1.50
2.02
5.9
6.4
1.22
1.03
mmol/l
0.23
35
278
5
11
4.58
1.94
1.0
1.2
—
—
—
0
0
8
27
2.99
1.94
1.0
1.3
—
—
—
0
0
47
317
1.53
1.94
1.8
1.7
—
—
—
0
0
68
495
1.43
1.93
1.4
1.2
10.98
7.33
u/ml
0.19
25
202
8
28
2.89
1.87
1.0
1.1
—
—
—
0
0
54
379
1.47
1.86
5.9
6.4
5.18
5.07
kpa
0.65
48
363
33
207
1.63
1.85
1.1
1.2
0.72
1.29
u/ml
0.43
21
129
5
12
4.20
1.82
1.0
1.2
—
—
—
0
0
75
564
1.39
1.78
3.8
4.4
12.13
14.01
mg/mmol
0.10
49
402
15
74
2.06
1.76
1.6
1.4
302.50
311.05
ug/g
—
6
44
32
202
1.62
1.76
1.2
1.2
2.46
2.85
u/ml
0.09
23
142
10
40
2.53
1.67
1.3
1.5
—
—
—
0
0
53
382
1.43
1.61
3.8
2.6
2707.32
5217.06
u/l
0.51
18
155
11
50
2.23
1.58
1.2
4.6
12.82
9.78
%
0.45
11
50
5
15
3.35
1.52
2.2
2.6
—
—
—
0
0
68
519
1.36
1.49
3.1
2.9
275.45
892.71
ng/l
1.14
31
297
10
45
2.25
1.47
1.1
1.1
—
—
—
0
0
12
226
0.52
1.45
1.7
1.7
—
—
—
0
0
38
263
1.48
1.43
1.5
1.3
199.08
272.14
miu/ml
0.55
12
134
13
236
0.54
1.40
1.8
1.6
—
—
—
0
0
11
53
2.10
1.39
1.5
1.1
—
—
—
0
0
13
68
1.94
1.34
1.4
1.3
—
20.14
—
0
5
28
185
1.54
1.32
1.3
1.6
325.57
175.89
u/ml
1.13
14
106
36
253
1.45
1.28
3.7
2.7
—
—
—
0
0
18
107
1.71
1.27
1.2
2.4
—
—
—
0
0
45
331
1.39
1.26
6.6
7.6
105.69
104.43
mmol/l
1.07
45
331
22
140
1.60
1.22
3.1
3.2
0.12
0.14
e6/l
0.09
22
133
8
40
2.02
1.12
1.3
1.3
—
—
—
0
0
8
40
2.02
1.12
1.3
1.3
—
—
—
0
0
17
104
1.66
1.10
1.3
1.2
—
—
—
0
0
144
1254
1.21
1.10
3.2
2.4
—
—
—
0
0
8
41
1.97
1.09
1.3
1.3
—
—
—
0
0
92
770
1.24
1.04
2.8
2.2
—
—
—
0
0
14
83
1.71
1.02
1.5
1.4
—
—
—
0
0
22
147
1.52
1.02
1.0
1.1
3.90
7.27
u/ml
0.81
14
93
9
49
1.85
0.99
1.1
4.6
—
—
—
0
0
27
191
1.44
0.96
1.3
1.5
—
—
—
0
0
6
28
2.16
0.91
1.3
1.2
338.00
167.39
iu/ml
—
6
28
6
29
2.08
0.89
1.8
1.9
—
—
—
0
0
7
129
0.54
0.89
1.4
1.9
—
—
—
0
0
17
111
1.55
0.88
1.6
1.9
—
—
—
0
0
8
43
1.87
0.87
1.1
4.9
33.25
27.53
%
—
8
43
19
128
1.50
0.87
1.1
1.1
1.64
7.12
u/ml
2.40
11
72
24
170
1.43
0.87
1.4
1.3
—
—
—
0
0
11
64
1.73
0.86
1.6
1.5
—
—
—
0
0
6
31
1.95
0.84
1.7
1.1
—
—
—
0
0
10
57
1.77
0.84
1.1
2.5
—
—
—
0
0
34
258
1.34
0.84
1.7
1.9
10.27
13.16
iu/l
0.45
24
188
18
121
1.51
0.83
1.7
2.0
—
—
—
0
0
36
463
0.76
0.83
1.2
1.4
—
—
—
0
0
6
32
1.88
0.82
1.0
1.3
—
—
—
0
0
18
122
1.49
0.81
1.7
2.1
39.78
41.07
u/l
0.13
18
114
25
182
1.39
0.79
1.4
1.8
2.91
2.94
mg/l
0.01
19
118
11
66
1.68
0.79
1.9
2.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
13
195
0.66
0.74
1.3
1.5
—
—
—
0
0
38
476
0.78
0.73
1.5
1.5
—
—
—
0
0
5
25
2.01
0.73
2.4
3.2
741.40
667.56
u/ml
—
5
25
19
134
1.43
0.72
1.0
1.1
—
—
—
0
0
5
26
1.93
0.71
1.0
1.0
—
—
—
0
0
17
118
1.46
0.70
1.1
1.1
—
—
—
0
0
7
41
1.72
0.70
1.3
1.3
—
—
—
0
0
22
161
1.38
0.69
3.6
3.1
87.33
145.19
ng/l
0.82
15
141
10
61
1.65
0.69
1.1
1.2
—
—
—
0
0
7
42
1.68
0.68
1.3
1.3
—
—
—
0
0
7
42
1.68
0.68
1.3
1.3
—
—
—
0
0
20
145
1.39
0.67
3.7
4.4
7.40
5.93
ug/l
0.10
15
113
19
137
1.40
0.65
1.0
1.2
—
—
—
0
0
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
27
207
1.32
0.65
1.5
1.3
—
—
—
0
0
14
95
1.49
0.64
1.6
1.4
—
—
—
0
0
14
95
1.49
0.64
1.6
1.4
—
—
—
0
0
5
29
1.73
0.64
1.4
1.3
—
—
—
0
0
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
176
1635
1.12
0.55
2.2
1.8
—
—
—
0
0
12
83
1.46
0.52
2.1
1.4
—
—
—
0
0
146
1349
1.11
0.50
3.4
2.5
—
—
—
0
0
30
244
1.24
0.49
8.5
9.6
0.59
0.72
mmol/l
0.11
23
193
7
45
1.56
0.49
2.7
1.4
—
—
—
0
0
14
102
1.38
0.47
2.7
2.0
3.05
7.19
iu/l
—
6
34
27
218
1.25
0.47
8.1
15.0
1.10
1.06
mg/l
0.14
27
210
7
49
1.43
0.46
1.4
1.5
—
—
—
0
0
15
113
1.34
0.43
1.1
1.1
—
—
—
0
0
5
31
1.62
0.43
6.4
3.4
23.60
26.77
umol/l
—
5
31
8
56
1.44
0.42
2.0
2.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
17
0.00
0.40
0.0
1.8
—
—
—
0
0
26
214
1.23
0.40
1.3
1.2
—
—
—
0
0
71
638
1.13
0.40
2.7
2.0
—
—
—
0
0
8
61
1.32
0.39
1.3
1.3
—
1.70
—
0
5
8
61
1.32
0.39
1.9
2.0
—
—
—
0
0
5
36
1.39
0.38
1.0
1.2
26.84
18.18
u/l
—
5
31
5
37
1.35
0.37
1.6
1.6
—
—
—
0
0
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
16
126
1.28
0.35
1.0
1.1
0.14
0.75
u/ml
—
7
57
6
44
1.37
0.34
2.3
2.3
—
—
—
0
0
23
195
1.19
0.28
1.5
2.7
86.67
81.07
ml/min/173m2
—
9
70
17
140
1.22
0.28
2.2
5.4
0.70
0.69
%
0.02
17
140
67
616
1.10
0.27
4.7
3.3
320.87
3217.29
umol/l
1.56
62
560
23
196
1.18
0.27
10.0
10.8
122.83
125.07
g/l
0.24
23
188
5
71
0.70
0.26
1.0
1.4
18.30
16.64
u/l
—
5
64
9
72
1.25
0.25
1.0
1.1
—
—
—
0
0
13
105
1.24
0.25
1.8
1.6
—
—
—
0
0
12
96
1.26
0.24
1.3
1.5
—
—
—
0
0
89
835
1.08
0.24
2.5
2.5
—
—
—
0
0
41
372
1.11
0.22
1.2
1.3
—
—
—
0
0
10
79
1.27
0.22
1.2
3.2
—
—
—
0
0
5
41
1.22
0.22
1.0
1.2
—
—
—
0
0
5
41
1.22
0.22
1.0
1.2
—
—
—
0
0
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
5
42
1.19
0.21
1.2
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
27.75
—
0
11
0
12
0.00
0.21
0.0
2.5
—
34.25
—
0
12
5
43
1.16
0.21
5.8
5.3
1.87
1.64
ug/l
—
5
43
24
211
1.14
0.21
1.4
1.4
—
—
—
0
0
20
229
0.87
0.20
1.6
1.4
—
—
—
0
0
7
58
1.21
0.18
2.0
2.1
—
—
—
0
0
39
359
1.09
0.17
2.4
2.3
13.84
12.88
nmol/l
0.17
34
335
8
69
1.16
0.16
2.1
1.8
1.39
5.53
ug/l
—
8
61
23
206
1.12
0.16
1.3
1.3
—
—
—
0
0
14
121
1.16
0.15
5.6
4.8
58.78
52.19
%
0.45
14
121
18
160
1.13
0.14
1.1
1.1
—
8.35
—
0
27
67
639
1.06
0.13
1.6
1.4
—
—
—
0
0
28
303
0.92
0.12
1.5
1.4
—
—
—
0
0
21
230
0.91
0.12
1.6
1.4
—
—
—
0
0
24
260
0.92
0.11
1.6
1.5
—
—
—
0
0
21
229
0.91
0.11
1.6
1.4
—
—
—
0
0
21
229
0.91
0.11
1.6
1.4
—
—
—
0
0
38
359
1.06
0.10
3.2
3.2
20.10
22.67
%
—
9
121
5
44
1.14
0.10
2.2
1.6
—
—
—
0
0
6
56
1.07
0.08
1.5
1.5
—
—
—
0
0
6
58
1.03
0.08
2.8
1.9
—
—
—
0
0
5
61
0.82
0.08
1.6
1.4
—
—
—
0
0
400
3973
1.03
0.08
4.1
3.8
—
—
—
0
0
7
65
1.08
0.08
2.0
1.9
—
—
—
0
0
7
65
1.08
0.08
2.0
1.9
—
—
—
0
0
13
118
1.10
0.07
4.7
4.7
24.40
24.48
mmol/l
0.04
13
113
10
89
1.13
0.07
1.7
1.9
—
—
—
0
0
11
121
0.91
0.06
1.3
1.2
—
—
—
0
0
161
1588
1.02
0.06
2.8
2.7
—
—
—
0
0
28
268
1.05
0.04
1.6
2.0
5.43
6.27
u/l
0.38
21
194
14
131
1.07
0.03
1.3
1.3
—
—
—
0
0
27
279
0.97
0.02
3.3
2.2
0.64
0.66
ug/l
0.05
15
139
24
248
0.97
0.02
2.1
1.8
—
—
—
0
0
11
116
0.95
0.00
4.6
11.1
24.64
24.30
mmol/l
0.17
11
106
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
5
52
0.96
0.00
1.4
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
9.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
7.36
—
0
8
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
49
1.02
-0.00
2.8
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
7.52
—
0
7
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
54
0.93
-0.00
2.4
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
9
90
1.00
-0.00
1.8
2.0
—
—
—
0
0
5
54
0.93
-0.00
2.4
2.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: F5_TIC – Tic disorders
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).